{"id":330373,"date":"2026-10-28T12:45:57","date_gmt":"2026-10-28T07:15:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=330373"},"modified":"2026-10-28T12:45:57","modified_gmt":"2026-10-28T07:15:57","slug":"branded-generics-exporter-latin-america-focused-drug-maker-and-largest-indian-pharmaceutical-company-stocks-roadmap-polaris-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-generics-exporter-latin-america-focused-drug-maker-and-largest-indian-pharmaceutical-company-stocks-roadmap-polaris-list\/","title":{"rendered":"3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma"},"content":{"rendered":"

Ajanta Pharma, Caplin Point Laboratories and Sun Pharma: ROE of 13.7% to 23.3% and FY22 to FY26 revenue CAGR of 11.6% to 15.2%. Prices as of 27 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three Africa, Latin America and specialty drug stocks to watch are Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Their return on equity ranges from 13.7% to 23.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.6% to 15.2%. Ajanta Pharma has the highest return on equity at 23.3%, while Caplin Point Laboratories has the fastest revenue growth at 15.2% a year. Prices are based on the 27 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Africa, Latin America and specialty drug stocks bring together companies with a visible plan for the years ahead. Ajanta Pharma, Caplin Point Laboratories and Sun Pharma cover a branded generics exporter, a Latin America focused drug maker and the largest Indian pharmaceutical company.<\/p>\n

This list covers three Africa, Latin America and specialty drug stocks with complete current figures: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Every figure comes from the latest reported financials and the 27 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n